Concepedia

Jorge Milone

JM

Statistics

Publications

13

Citations

1.5K

H-Index

13

Active since

1998

Affiliations

Bristol-Myers Squibb (United States)(Current)

Hospital Italiano La Plata

The University of Texas MD Anderson Cancer Center

Heidelberg University

University of California, San Francisco

Jorge Milone is an author at Bristol-Myers Squibb (United States) specializing in medicine, chronic myeloid leukemia therapy, and oncology pharmacotherapy.

Publications per year

1998–2016

13

Publications

13

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Hagop M. Kantarjian, Neil P. Shah, Jörge E. Cortes et al. · Blood · 2011 · 605 citations · Full text

, , +8

Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia

Neil P. Shah, Hagop M. Kantarjian, Dong‐Wook Kim et al. · Journal of Clinical Oncology · 2008 · 488 citations · Full text

, , +15

Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034

Neil P. Shah, Philippe Rousselot, Charles A. Schiffer et al. · American Journal of Hematology · 2016 · 181 citations · Full text

, , +9

T-Cell Lymphomas in South America and Europe

Monica Bellei, Carlos Chiattone, Stefano Luminari et al. · Revista Brasileira de Hematologia e Hemoterapia · 2011 · 59 citations · Full text

, , +13

Identification of mRNA decapping activities and an ARE-regulated 3' to 5' exonuclease activity in trypanosome extracts

Jorge Milone · Nucleic Acids Research · 2002 · 39 citations · Full text

, , +17

1–5 of 13